Panmure Liberum announces the launch of its new brand, new product areas and confirms Senior Executive Team and Department Heads
New Debt Advisory and specialised Private Capital offer broadens Panmure Liberum’s capabilities and underlines its growth ambitions, with all functions and business lines now fully consolidated.
Panmure Liberum today announces the launch of its new brand and two new product areas in Debt Advisory and specialised Private Capital as part of the enlarged Group’s new growth ambitions. The Company also confirms its Senior Executive Team and announces its new Department Heads across Investment Banking, Research, Execution and Sales, as the fully consolidated Group comes together to serve clients from one office at 25 Ropemaker Street.
When the merger was announced on 16 January this year, the enlarged Group expressed its clear ambition to widen and diversify its offering to clients. The launch of two new service lines specialising in Debt Advisory and Private Capital marks an early proof point of strategic delivery.
The new Debt Advisory team led by Dan Howlett, Vice Chair, Head of Debt Advisory and Ben Handler Managing Director, Head of Business Origination will work closely with and as part of the wider Investment Banking business to provide advice to corporate clients across the capital structure. The unit will support clients to structure, price and access pools of liquidity from lending banks and debt funds for a full spectrum of purposes, including day-to-day working capital, capex, M&A, pre-/post-IPO, rescue capital and structured financing.
The specialised Private Capital offering based in Cambridge, Panmure Liberum Cambridge Capital (“PLCC”) supports innovative and growing companies in the healthcare and life sciences sector to access capital from its global network of investors. The team provides guidance throughout the entire business lifecycle, including all stages of private funding. Led by Freddy Crossley and Ed Rayner, who are highly experienced in funding and advising healthcare and life sciences companies, PLCC acts as a dedicated centre of excellence for Panmure Liberum to scale its private capital raising activities, and accelerate investment into world-class science and innovation.
These launches follow the recently announced expansion of Panmure Liberum’s US business with the appointment of Ed Husband, Hugo Hewitt and Arthur Pyott from the former Numis US business.
Senior Executive Team and Department Heads
As previously announced, Rich Ricci will lead Panmure Liberum as CEO. The Senior Executive Team will also include Bidhi Bhoma as Deputy CEO, Richard Morecombe as President, Head of Origination & Business Development, David Parsons as Head of Equities and Matthew Press as Chief Operating Officer.
The newly appointed Department Heads are Dru Danford (Head of Investment Banking), Stephen Jones (Chair of Investment Banking), Simon French (Head of Research), Adam Howson (Head of Execution) and Oliver Baxendale (Head of Equity Sales).
Full consolidation of combined businesses
Following completion of the merger in May, all functions and business lines are now fully consolidated, with the combined business sitting in one office at 25 Ropemaker Street. This includes Panmure Liberum’s waterfront UK Research offering and combined Execution desk, which is market maker in over 720 stocks with All-Cap execution capabilities across the UK, US, Europe and Asia servicing over 900 market counterparties.
Panmure Liberum has also launched a refreshed website, brand, and social channels to reflect the business’ new corporate identity.
Rich Ricci, Chief Executive Officer of Panmure Liberum, said: “Today marks a major step forward in our ambitions to create a new, positive force in UK Investment Banking. Together, and with the support of Atlas Merchant Capital, we have quickly identified and built new capabilities to meet the changing needs of our clients and our institutional network. Our enlarged business, deep talent pool and ambitious growth strategy has already attracted some of the sector’s leading practitioners, adding to our long-term prospects and the significant market opportunity. As a fully consolidated business now operating under one roof, we are hugely excited about the journey ahead.”